[TLV meets criticism: costs of antihypertensive agents can and should be reduced]

Lakartidningen. 2008 Sep;105(38):2592-3.
[Article in Swedish]
No abstract available

Publication types

  • Comment

MeSH terms

  • Antihypertensive Agents / economics*
  • Drug Costs
  • Drug Industry / economics
  • Humans
  • Insurance, Health / economics
  • Insurance, Pharmaceutical Services / economics

Substances

  • Antihypertensive Agents